VMP 35899411000001101

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Alteplase 50mg powder and solvent for solution for infusion vials
BNF code 0210020V0AAACAC
Virtual Therapeutic Moiety Alteplase
Date identifier became valid 17 Oct 2018
Previous product identifier 319837006
Abbreviated name Alteplase 50mg inf vials
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 11 May 2009
Previous name Alteplase 50mg powder and solvent for solution for injection vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units vial
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Alteplase
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Powder and solvent for solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Actilyse 50mg powder and solvent for solution for infusion vials (Boehringer Ingelheim Ltd)
Virtual Medicinal Product Packs
Alteplase 50mg powder and solvent for solution for infusion vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_6.4.0_20200629000001, imported on 30th June 2020 at 05:07:36.